The fasciitis-panniculitis syndromes: Clinical and pathologic features

Medicine

Volumn 75, Issue 1, 1996, Pages 6-16

  Naschitz, Jochanan E ^a   Boss, Jochanan H ^a,b   Misselevich, Ines ^a   Yeshurun, Daniel ^a   Rosner, Itzhak ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHLOROQUINE; CIMETIDINE; CORTICOSTEROID; COUMARIN; METHOTREXATE; PENICILLAMINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; FASCIITIS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MYXEDEMA; PANNICULITIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT; SYNDROME DELINEATION;

ADIPOSE TISSUE; ADRENAL CORTEX HORMONES; CIMETIDINE; DIAGNOSIS, DIFFERENTIAL; FASCIITIS; HISTAMINE H2 ANTAGONISTS; HUMANS; LYMPHOCYTES; PANNICULITIS; SKIN; SYNDROME;

EID: 0030053890     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199601000-00002     Document Type: Article

References (59)

1. Abeles M, Belin DC, Zurier RB. Eosinophilic fasciitis. A clinico-pathologic study. Arch Intern Med 139: 586-88, 1979.
2. Ackerman AB. Histologic diagnosis of inflammatory skin diseases. Philadelphia: Lea and Febiger, pp. 784-96, 1978.
3. Alonso-Ruiz A, Zea-Mendoza AC, Salazar-Vallinas JM, Rocamora-Ripoll A, Beltran-Guttrierrez D. Toxic oil syndrome: A syndrome with features overlapping those of various forms of scleroderma. Semin Arthritis Rheum 15: 200-12, 1986.
4. Atherton DG, Wells RS. Scleredema of Buschke? Eosinophilic fasciitis. Br J Dermatol 95(Suppl 14): 36-37, 1976.
5. Attias D, Laor R, Zuckermann E, Naschitz JE, Luria M, Misselevitch I, Boss JH. Acute neutrophilic myositis in Sweet's syndrome. Late phase transformation into fibrosing myositis and panniculitis. Human Pathol 26: 687-90, 1995.
6. Avella J, Madsen JE, Binder HJ, Askenase PW. Effect of histamine H2-receptor antagonist in delayed hypersensitivity. Lancet 1: 624-46, 1978.
7. Barnes L, Rodnan GP, Medsger TA Jr, Short D. Eosinophilic fasciitis. A pathologic study of twenty cases. Am J Pathol 96: 493-507, 1979.
8. Boss JH, Sabo E, Shajrawi I, Misselevich I, Kalderon N, Yeshurun D, Naschitz JE. The fasciitis-panniculitis reaction pattern. In: Santoscoy GG, ed. Volume of the XVII World Congress of Anatomic and Clinical Pathology. Bologna: Monduzzi Editore, pp. 551-55, 1994.
9. Brent LH, Abruzzo JL. Localized eosinophilic fasciitis in a patient with rheumatoid arthritis. J Rheumatol 12: 987-89, 1985.
10. Bull RH, Coburn PR, Mortimer PS. Pretibial myxoedema: A manifestation of lymphedema? Lancet 341: 403-4, 1993.
11. Caperton EM, Hathaway DE. Scleroderma with eosinophilia and hypergammaglobulinemia: The Shulman syndrome [abstract]. Arthritis Rheum 18: 391, 1975.
12. Casley-Smith JR, Gaffney RM. Excess plasma proteins as a cause of chronic inflammation and lymphedema: Quantitative electron microscopy. J Pathol 133: 243-72, 1981.
13. Casley-Smith JR, Morgan RG, Pillar NB. Treatment of lymphedema of the arms and legs with 5,6-benzo-(α)-pyrone. N Engl J Med 329: 1158-63, 1993.
14. Chung EB, Enzinger FM. Proliferative fasciitis. Cancer 36: 1450-58, 1975.
15. Claman N. Mast cells and fibrosis. The relevance to scleroderma. Rheumatol Dis Clin North Am 16: 141-51, 1990.
16. Colver GB, Rodger A, Mortimer S, Savin JA, Naill SM, Hunter JAA. Post-irradiation morphoea. Br J Dermatol 12: 831-35, 1989.
17. de Almeida Prestes C, Winkelmann RK, Su WP. Septal granulomatous panniculitis: Comparison of the pathology of erythema nodosum migrans (migratory panniculitis) and chronic erythema nodosum. J Am Acad Dermatol 22: 477-83, 1990.
18. Falanga V. Localized scleroderma. Med Clin North Am 73: 1143-56, 1989.
19. Farrington ML, Haas JE, Nazar-Stewart V, Mellins ED. Eosinophilic fasciitis in children frequently progresses to scleroderma-like cutaneous fibrosis. J Rheumatol 20: 128-32, 1993.
20. Freundlich B, Werth VP, Rook AH, O'Connor CR, Schumacher HR, Leyden JJ, Stolley PD. L-tryptophane injection associated with eosinophilic fasciitis but not progressive systemic sclerosis. Ann Intern Med 112: 758-62, 1990.
21. Garcia-Morteo O, Maldonado-Cocco JA, Bareira JC. Cimetidine and eosinophilic fasciitis. Ann Intern Med 100: 318, 1984.
22. Hoffman R, Dainiak N, Sibrack L. Antibody-mediated aplastic anemia and diffuse fasciitis. N Engl J Med 300: 718-21, 1979.
23. Jacobs MB. Eosinophilic fasciitis, reactive hepatitis and splenomegaly. Arch Intern Med 145: 162-63, 1985.
24. Janin A, Socie G, Devergie A, Aractingi S, Esperou H, Verola O, Gluckman E. Fasciitis in chronic graft-versus-host disease. A clinicopathologic study of 14 cases. Ann Intern Med 120: 993-98, 1994.
25. Kaplinski N, Revach M, Katz WA. Eosinophilic fasciitis: Report of a case with features of connective tissue disease. J Rheumatol 7: 536-40, 1980.
26. Knighton DR, Silver IA, Hunt TK. Regulation of wound-healing angiogenesis. Effect of oxygen gradients and inspired oxygen concentration. Surgery 90: 262-69, 1981.
27. Lakhanpal S, Ginsburg WW, Michet CJ, Doyle JA, Moore SB. Eosinophilic fasciitis: Clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum 17: 221-31, 1988.
28. LeRoy EC. Raynaud's phenomenon, scleroderma, overlap syndromes, and other fibrosing syndromes. Curr Opinion Rheumatol 4: 821-24, 1993.
29. LeRoy EC, Black CM, Fleischmajer R, Jablonska S, Krieg T, Medsger TA, Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 15: 202-5, 1988.
30. Lupton JP, Goette DK. Localized eosinophilic fasciitis. J Rheumatol 7: 541-43, 1980.
31. Magaro A, Altomonte L, Zoli A, Mirone L, Massi G, Federico F. Eosinophilic fasciitis associated with inflammatory neutrophilic vasculitis. Br J Rheumatol 29: 145-46, 1990.
32. Malane MS, Grant-Kels JM, Feder HM Jr, Luger SW. Diagnosis of Lyme disease based on dermatologic manifestations. Ann Intern Med 114: 490-98, 1991.
33. Mavligit GM. Immunologic effects of cimetidine: Potential uses. Pharmacotherapy 7(Suppl 2): 1205-45, 1987.
34. Mehm WJ, Pimsler M, Becker RL. Effect of oxygen on in vitro fibroblast cell proliferation and collagen biosynthesis. J Hyperbaric Med 3: 227-34, 1988.
35. Minna JD, Bunn PA Jr. Paraneoplastic syndromes. In: DeVita VT Jr, Helman S, Rosenberg SA, eds. Cancer: Principles and practice of oncology. Philadelphia: JB Lippincott, pp. 1476-1517, 1982.
36. Misselevich I, Podoshin L, Fradis M, Naschitz JE, Yeshurun D, Boss JH. Inflammatory pseudotumor of the neck. Otolaryngol Head Neck Surg 105: 864-67, 1991.
37. Moore TL, Zuckner J. Eosinophilic fasciitis. Semin Arthritis Rheum 9: 228-35, 1980.
38. Naschitz JE, Yeshurun D, Misselevitch I, Boss JH. Colitis and pericarditis in a patient with eosinophilic fasciitis. A contribution to the multisystem nature of eosinophilic fasciitis. J Rheumatol 16: 688-92, 1989.
39. Naschitz JE, Yeshurun D, Misselevitch I, Boss JH. Downslope claudication in eosinophilic fasciitis: A fourth type of claudication - case presentations. Angiology 42: 167-71, 1991.
40. Naschitz JE, Yeshurun D, Schwartz H, Croitoru S, Shajrawi I, Misselevitch I, Boss JH. Pathogenesis of lipodermatosclerosis of venous disease: The lesson learned from eosinophilic fasciitis. Cardivasc Surg 1: 524-29, 1994.
41. Naschitz JE, Yeshurun D, Shajrawi I, Misselevich I, Boss JH. The phlebopathies of the fasciitis panniculitis syndrome. Scand J Rheumatol 21: 24-27, 1992.
42. Naschitz JE, Yeshurun D, Zuckerman E, Rosenbaum M, Misselevitch I, Shajrawi I, Boss JH. Cancer-associated fasciitis panniculitis. Cancer 73: 231-35, 1994.
43. Naschitz JE, Yeshurun D, Zuckerman E, Rosner I, Shajrawi I, Misselevitch I, Boss JH. The fasciitis-panniculitis syndrome: Clinical spectrum and response to cimetidine. Semin Arthritis Rheum 21: 211-20, 1992.
44. Person JR, Su WPD. Subcutaneous morphoea: A clinical study of sixteen cases. Br J Dermatol 100: 371-80, 1979.
45. Philen RM, Posada M. Toxic oil syndrome and eosinophilia-myalgia syndrome. Semin Arthritis Reum 23: 104-24, 1993.
46. Rocco VK, Hurd ER. Scleroderma and scleroderma-like disorders. Semin Arthritis Rheum 16: 22-69, 1986.
47. Rodnan GP, DiBartolomeo AG, Medsger TA Jr, Barnes EL Jr. Eosinophilic fasciitis: Report of 7 cases of a newly recognized scleroderma-4 like syndrome [abstract]. Arthritis Rheum 18: 122-23, 1978.
48. Rosenthal J, Benson MD. Diffuse fasciitis and eosinophilia with symmetric polyarthritis. Ann Intern Med 92: 507-9 1980.
49. Rozboril MB, Maricq HR, Rodnan GP, Jablonska S, Bole GG. Capillary microscopy in eosinophilic fasciitis. A comparison with systemic sclerosis. Arthritis Rheum 23: 617-21, 1983.
50. Shulman LE. Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: A new syndrome. J Rheumatol 1(Suppl): 56, 1975.
51. Shulman LE. The eosinophilia-myalgia syndrome associated with ingestion of L-tryptophane. Arthritis Rheum 33: 913-17, 1990.
52. Silber TJ, Kastrinakis M, Taube O. Painful red leg nodules and syphilis: A consideration in patients with erythema nodosum-like illness. Sex Trans Dis 14: 52-53, 1987.
53. Solomon G, Barland P, Rifkin H. Eosinophilic fasciitis responsive to cimetidine. Ann Intern Med 97: 547-49, 1982.
54. Su WP, Person JR. Morphea profunda: A new concept and a histopathologic study of 23 cases. Am J Dermatopathol 3: 251-60, 1981.
55. Tuffanelli DL. Systemic scleroderma. Med Clin North Am 73: 1167-80, 1987.
56. Varga J, Jimenez SA. Chemical exposure-induced cutaneous fibrosis. Lessons from "experiments of nature." Arch Dermatol 130: 97-100, 1994.
57. Varga J, Uitto J, Jimenez SA. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med 116: 140-47, 1992.
58. Winkelmann RK, Foerstroem L. New observations in the histopathology of erythema nodosum. J Invest Dermatol 65: 441-16, 1975.
59. Zuckerman E, Naschitz JE, Yeshurun D, Wellisch G, Shajrawi I, Boss JH. Fasciitis-panniculitis in acute brucellosis. Int J Dermatol 33: 57-59, 1994.